Clinical trial
Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer
NCT05658172
Study timeline
Study start (actual)2022-12-07Date precision: day
Registry last updated2025-05-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
Determination of tumormarkers (CA27.29, CEA, CA125)DIAGNOSTIC_TEST
Determination of CTC levelsDIAGNOSTIC_TEST
Determination of ctDNA levelsDIAGNOSTIC_TEST
Sponsors & collaborators
Prof. Wolfgang Jannilead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05658172 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.